Cooley advised the joint sponsors and underwriters on the deal while O’Melveny represented Cryofocus Medtech (Shanghai) Co., Ltd. Cryofocus Medtech announced its HK$210 million ($27 million) initial...
Cryofocus Medtech’s HK$210 Million IPO
Asymchem’s $917 Million Hong Kong Listing
Latham & Watkins LLP advised the underwriters in the transaction while Cooley and JunHe represented Asymchem Laboratories. Asymchem Laboratories (Tianjin) Co., Ltd (Asymchem), a leading drug...
Keymed Biosciences’ US$400 Million Hong Kong IPO
O’Melveny & Myers and Cooley LLP advised Keymed Biosciences Inc. on the deal, while Kirkland & Ellis advised the joint sponsors and underwriters. Keymed Biosciences Inc....